<DOC>
	<DOCNO>NCT03019679</DOCNO>
	<brief_summary>In study investigator aim investigate whether relation polycystic ovary syndrome serum endocan level .</brief_summary>
	<brief_title>Serum Endocan Levels Polycystic Ovary Syndrome</brief_title>
	<detailed_description>Polycystic ovary syndrome disorder associate insulin resistance , diabetes , obesity , cardiovascular disease . Endothelial dysfunction , know early marker atherosclerosis , also show association poycystic ovary syndrome . In study investigator aim investigate whether relation polycystic ovary syndrome serum endocan level . For purpose investigator design prospective study include two group . The diagnosis polycystic ovary syndrome make presence ; oligo- and/or anovulation , clinical hyperandrogenism polycystic ovary . Clinical hyperandrogenism define presence hirsutism , acne , presence androgenic alopecia , body mass index ( BMI ) calculate weight kilogram divide square height meter . The two group compare consider serum endocan level , follicle stimulate hormone ( FSH ) , luteinizing hormone ( LH ) , Dihydroepiandesterone sulphate ( DHEAS ) , total testesterone ( TT ) , estradiol ( E2 ) thyroid stimulate hormone ( TSH ) , fast blood glucose , triglyceride , total cholesterol , high density lipoprotein , low density lipoprotein , C-reactive protein ( CRP ) level .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>18 45 year Patients diagnose PCOS accord Rotterdam criteris ( study group ) Patients without PCOS menstrual irregularity ( control group ) Absence significant abnormality physical examination except hirsutism No lipid lowering , hypoglycemic , antihypertensive hormone replacement therapy Normal thyroid function prolactin level Absence history evidence metabolic , cardiovascular , respiratory hepatic disease Pregnant Ovarian tumor Endocrine disease ( Cushing disease , 21Hydroxylase enzyme deficiency , thyroid dysfunction , hyperprolactinemia , diabetes ) Chronic disease ( renal insufficiency , cardiovascular , hepatic disease ) Oral contraceptive use , antiandrogenic , glucocorticoid , antihypertansive antidiabetic drug use Smoking alcohol use</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>